Heraeus reports improved 1994
This article was originally published in Clinica
German-based Heraeus has reported an improved 1994 with sales up 12% to DM 5,491 million ($4,008 million) compared with a weak 1993. The revenue figures exclude trade in precious metals. Net income was DM 72 million compared with DM 43 million a year earlier.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.